For the quarter ending 2025-10-31, HSCSW made $2,419 in revenue. -$2,350,769 in net income. Net profit margin of -97179.37%.
| Income Statement | 2025-10-31 | 2025-07-31 | ||
|---|---|---|---|---|
| Revenue | 2,419 | 1,900 | ||
| Cost of sales | 1,008 | 760 | ||
| Gross margin | 1,411 | 1,140 | ||
| Research and development | 727,026 | 997,206 | ||
| Selling, general and administrative | 1,347,788 | 878,053 | ||
| Total operating expenses | 2,074,814 | 1,875,259 | ||
| Loss from operations | -2,073,403 | -1,874,119 | ||
| Interest expense | 279,534 | 183,688 | ||
| Other income | 2,168 | 2,813 | ||
| Total other expense | -277,366 | -180,875 | ||
| Net loss | -2,350,769 | -2,054,994 | ||
| Earnings per share, basic, total | -0.85 | -1.58 | ||
| Earnings per share, diluted, total | -0.85 | -1.58 | ||
| Weighted average number of shares outstanding, basic, total | 2,780,496 | 1,303,532 | ||
| Weighted average number of shares outstanding, diluted, total | 2,780,496 | 1,303,532 | ||
HeartSciences Inc. (HSCSW)
HeartSciences Inc. (HSCSW)